-
ZSHK Laboratories Raises RMB 100 Million in Series B Financing Round
•
China-based pre-clinical Contract Research Organization (CRO) ZSHK Laboratories Limited has reportedly raised close to RMB 100 million (USD 13.89 million) in a Series B financing round. The round was led by a fund jointly initiated by AstraZeneca and CICC Capital, with participation from existing investor Ascendum Capital. The proceeds will…
-
Anyeep Raises RMB 100 Million in Series A Financing for Mass Spectrometry Development
•
Anyeep, a Suzhou-based developer of mass spectrometers, has reportedly raised close to RMB 100 million (USD 13.96 million) in a Series A financing round. The round was led by Greenriver Capital, with participation from Dunhang Investment, PEAKVEST FOF, and existing investors Frees Fund and Yuanbio Venture Capital. The proceeds will…
-
Xiling Lab Raises RMB 100 Million for ADC Development and IND Filing
•
Xiling Lab, a Chengdu-based drug developer specializing in catalytic synthesis technology, has reportedly raised close to RMB 100 million (USD 13.96 million) in a Pre-Series B financing round. Investors included Chengdu Bio City No. 1 Equity Investment Fund, Chengdu Gaoxin New Economy Venture Capital, Pengzhou Global Biomedical Technology Achievement Transformation…
-
PrimeLink Bio Raises Funds for ADC Development and R&D Expansion
•
Shenzhen-based drug developer PrimeLink Bio has reportedly raised “hundreds of millions” of renminbi in a new financing round led by Vertex Ventures. Fosun Pharma and Kaitai Capital also participated in the round. The proceeds will be used to support technology research and development (R&D), talent recruitment, and laboratory construction. Company…
-
Saint Medical Raises Pre-Series B Funding for Structural Heart Disease Solutions
•
Saint Medical Technology, a Nanjing-based medical device maker specializing in valvular disease solutions, has reportedly raised “tens of millions” of renminbi in a Pre-Series B financing round. The round was led by Jinpu Intelligent Manufacturing Fund, with participation from Wuxi Capital and Hexingcheng Fund. The proceeds will be used to…
-
Endoso Life Raises Pre-Series A Funding for High-End Medical Endoscope Development
•
Endoso Life, a Hangzhou-based developer of high-end medical endoscope systems and devices, has reportedly raised “tens of millions” of renminbi in a Pre-Series A financing round. The round was led by BGI Co-Win, with participation from Findowin Capital. The proceeds will be used to support research and development of high-end…
-
Fapon Biotech Partners with CR Pharma to Develop IVD Open Platform Ecosystem
•
China-based biotech Fapon Biotech Inc. has announced a partnership with China Resources Pharmaceutical Commercial Group Medical Device Co., Ltd to develop an in vitro diagnostics (IVD) open platform ecosystem. The collaboration aims to enhance the development and market presence of IVD solutions. Financial details of the partnership were not disclosed.…
-
RongCan Biotech Raises Pre-Series A Funding for mRNA Therapeutics Development
•
China-based nucleic acid-based therapeutics developer RongCan (Shanghai) Biotech Co., Ltd has reportedly raised “tens of millions” of renminbi in a Pre-Series A financing round led by a “reputational healthcare fund.” The proceeds will be used to accelerate product research and development (R&D), team building, and clinical studies for leading pipelines.…
-
Subtle Medical Secures Series B Funding for AI-Powered Medical Imaging
•
Subtle Medical, an Artificial Intelligence (AI)-empowered medical imaging company based in Guangdong, has reportedly raised “tens of millions” of US dollars in a Series B financing round. The round was led by Eastern Bell Capital and Primavera Venture Partners, with contributions from Fusion Fund, 3E Bioventures, Banyan Pacific Capital, Delta…
-
Rainsure Scientific Secures Series C1 Funding for Digital PCR Development
•
Rainsure Scientific, a Suzhou-based developer of digital PCR instruments and RUO detection kits, has reportedly raised “tens of millions” of renminbi in a Series C1 financing round led by Qiaodao Investment Fund. The proceeds will be used to further develop and commercialize the company’s innovative molecular diagnostics products. Company ProfileFounded…
-
MicroTech Medical Plans IPO on Shanghai’s STAR Market
•
China-based diabetes specialist MicroTech Medical (Hangzhou) Co., Ltd (HKG: 2235) has announced plans to conduct an initial public offering (IPO) of 93.46 million shares on the Shanghai Stock Exchange’s Sci-Tech Innovation Board (STAR). The listing price remains unknown at this stage. Company ProfileFounded in 2011, MicroTech Medical specializes in diabetes…
-
Lupeng Pharma Raises USD 35 Million in Pre-Series B Financing Round
•
China-based Lupeng Pharmaceutical Ltd has reportedly raised USD 35 million in Phase 2 of a Pre-Series B financing round. The round was led by Kaitai Capital and Temasek, with participation from Lilly Asia Ventures, Fontus Capital, and Lake Bleu Capital. The proceeds will be used to support clinical studies for…
-
BRL Medicine Raises RMB 200M in Series B Financing for CGT Development
•
BRL Medicine Inc., a cell and gene therapy (CGT) developer based in Shanghai, has reportedly raised over RMB 200 million (USD 28.3 million) in a Series B financing round. The round was led by Shanghai FTZ Fund, with participation from Oriental Fortune Capital, Tasly Capital, Betta Biomedical Industry Fund, and…
-
AstraZeneca and CICC Capital Launch RMB 3 Billion Fund in Hangzhou
•
The joint venture (JV) between UK pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) and China’s CICC Capital has launched its Hangzhou unit, backed by an RMB 3 billion (USD 425.5 million) fund. The fund is supported by multiple local government guidance funds, funds of funds, and medical industry funds, including Hangzhou…
-
Zenas BioPharma Completes $118M Series B Financing to Advance Obexelimab
•
Autoimmune disease drug developer Zenas BioPharma, which is based in the US and China, has announced the completion of a Series B financing round at USD 118 million. The round was led by Enavate Sciences, with participation from Longitude Capital, Vivo Capital, Rock Springs Capital, Perceptive Advisors, Agent Capital, Pivotal…
-
Innovex Medical Files for IPO in Hong Kong to Boost Product Development
•
Innovex Medical Co., Ltd, a non-vascular interventional surgery solutions provider based in Shanghai, has filed an initial public offering (IPO) with the Hong Kong Stock Exchange. The IPO is co-sponsored by Goldman Sachs and CICC. While the price has not been disclosed at this stage, the proceeds will be used…
-
ChainGen Bio Raises RMB 45M in Angel Round for X-oligo Conjugates Development
•
ChainGen Bio, a Shanghai-based developer of X-oligo conjugates (XOCs), has reportedly raised RMB 45 million (USD 6.2 million) in an angel financing round co-led by Matrix Partners and Frees Fund. The proceeds will be used to advance pipeline research and development, patent layout, and company operations, including laboratory platform construction.…
-
Yibao Technology Secures Series A+ Funding to Expand Health Insurance Services
•
Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (“Huiminbao”) schemes, has reportedly raised an undisclosed amount in a Series A+ financing round. The round was led by China Resources Pharmaceutical Group Ltd, China Resources Medicine Commercial Holdings Ltd, and China Resources Sanjiu Medical & Pharmaceutical…
-
Mainline Biosciences Raises RMB 100M in Series A Financing for Peptide Drugs
•
Mainline Biosciences, a polypeptide drug developer based in Zhongshan, has reportedly raised close to RMB 100 million (USD 13.8 million) in a Series A financing round. The round was led by Fuho Capital, with participation from Techsnow Capital and Dingfu Investment. The proceeds will be used to construct the company’s…
-
Jiangsu Trausim Raises RMB 100M in Series A Financing for Dental Implants
•
China-based Jiangsu Trausim Medical Instrument Co., Ltd, a wholly-owned subsidiary of Fulong Holdings and focused on dental implants and surgical instruments, has reportedly raised close to RMB 100 million (USD 13.8 million) in a Series A financing round. The round was led by Sunho Capital and MF Capital, with participation…
